ASCLEPIOS S.A. secures contract for Pharmaceutical Products - Delivery of cytostatic drugs, including cytostatic drugs necessary to perform benefits in the field of chemotherapy and drug programs for the needs of the Beskid Oncology Center - Municipal Hospital of the John Paul II in Bielsko - Biala

Poland, June 6 -- Poland based ASCLEPIOS S.A. has secured contract from Beskidzkie Centrum Onkologii- Szpital Miejski im. Jana Pawla II w Bielsku-Bialej. for Pharmaceutical Products - Delivery of cytostatic drugs, including cytostatic drugs necessary to perform benefits in the field of chemotherapy and drug programs for the needs of the Beskid Oncology Center - Municipal Hospital of the John Paul II in Bielsko - Biala. The value of the contract is worth 32003520 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....